Analyze Diet

Influence of cyclooxygenase inhibitors on furosemide-induced hemodynamic effects during exercise in horses.

Abstract: Furosemide, which commonly is used as a prophylactic treatment for exercise-induced pulmonary hemorrhage in horses, may mediate hemodynamic changes during exercise by altering prostaglandin metabolism. To determine if furosemide's hemodynamic effects during exercise in horses could be reversed, cyclooxygenase inhibitors were administered with furosemide. Four treatments were administered 4 hours prior to treadmill exercise at 9 and 13 m/s. They included a control treatment (10 ml of 0.9% NaCl solution, IV), furosemide (1 mg/kg of body weight, IV) administered alone, and furosemide in combination with phenylbutazone (4 mg/kg, IV, q 12 h for 2 days) or with flunixin meglumine (1.1 mg/kg, IV, on the day of experiment). Five horses were randomly assigned to complete all treatments. Physiologic variables at rest prior to exercise were not influenced by treatments. Furosemide, administered alone, reduced mean right atrial pressure and mean pulmonary artery pressure during exercise. The combinations of furosemide and flunixin meglumine or furosemide and phenylbutazone, at both levels of exercise intensity, returned mean right atrial pressure and mean pulmonary artery pressure to the value of the control treatment. During rest and exercise, plasma lactate concentration, PCV, heart rate, mean carotid artery pressure, oxygen consumption, carbon dioxide elimination, and cardiac output were not altered by any of the treatments. At 5 minutes after exercise, the administration of furosemide, alone or with phenylbutazone, reduced mean right atrial pressure. Other measured variables were not significantly influenced by treatments during recovery from exercise. These results suggested that cyclooxygenase inhibition partially reverses the decrease in mean right atrial pressure or pulmonary artery pressure induced by furosemide during exercise.(ABSTRACT TRUNCATED AT 250 WORDS)
Publication Date: 1992-09-01 PubMed ID: 1416355
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't
  • Research Support
  • U.S. Gov't
  • Non-P.H.S.

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This study was designed to investigate if the impact furosemide has on blood flow during exercise in horses could be counteracted with the use of cyclooxygenase inhibitors. The results indicated that the combination of furosemide and either of the cyclooxygenase inhibitors tested were able to return certain metrics of cardiovascular performance back to control levels during exercise but did not affect the other examined variables.

Objective of the Study

The purpose of this research was to understand whether the hemodynamic effects (relating to the flow of blood within the organs and tissues of the body) caused by furosemide, a drug used to prevent exercise-induced pulmonary hemorrhage in horses, could be counteracted by using cyclooxygenase inhibitors, a class of drugs that reduce inflammation.

Methodology

  • Four different treatments were tested, each administered to five horses 4 hours before a treadmill exercise at two different speeds.
  • The control group received a 10ml quantity of saline solution, administered intravenously.
  • One group received furosemide alone, dosed at 1mg/kg of body weight, intravenously.
  • The two other groups received furosemide combined with either phenylbutazone (a nonsteroidal anti-inflammatory drug) or flunixin meglumine (another nonsteroidal anti-inflammatory drug).

Results

  • The researchers found that when administered alone, furosemide reduced both mean right atrial pressure and mean pulmonary artery pressure during exercise.
  • However, when furosemide was combined with either of the two cyclooxygenase inhibitors, these two pressure metrics were restored to control levels.
  • In terms of other variables examined, such as plasma lactate concentration, pulse rate, mean carotid artery pressure, oxygen consumption, carbon dioxide elimination, and cardiac output, no changes were observed under any of the treatments.
  • Even during the recovery period post-exercise, these metrics remained unaffected by the treatments barring a decrease in mean right atrial pressure when horses were administered furosemide alone or combined with phenylbutazone.

Conclusion

From the results, it can be concluded that the hemodynamic effects induced by furosemide during exercise in horses were partially reversed by co-administration with cyclooxygenase inhibitors. However, only select parameters, namely mean right atrial pressure and mean pulmonary artery pressure, were positively affected while other physiological variables remained relatively unaltered.

Cite This Article

APA
Olsen SC, Coyne CP, Lowe BS, Pelletier N, Raub EM, Erickson HH. (1992). Influence of cyclooxygenase inhibitors on furosemide-induced hemodynamic effects during exercise in horses. Am J Vet Res, 53(9), 1562-1567.

Publication

ISSN: 0002-9645
NlmUniqueID: 0375011
Country: United States
Language: English
Volume: 53
Issue: 9
Pages: 1562-1567

Researcher Affiliations

Olsen, S C
  • Department of Anatomy, College of Veterinary Medicine, Kansas State University, Manhattan 66506.
Coyne, C P
    Lowe, B S
      Pelletier, N
        Raub, E M
          Erickson, H H

            MeSH Terms

            • Animals
            • Blood Pressure / drug effects
            • Clonixin / analogs & derivatives
            • Clonixin / pharmacology
            • Heart Rate / drug effects
            • Hemodynamics / drug effects
            • Horses / physiology
            • Lactates / blood
            • Male
            • Phenylbutazone / pharmacology
            • Physical Exertion / physiology
            • Random Allocation

            Citations

            This article has been cited 0 times.